https://medicaldialogues.in/oncology/news/trastuzumab-deruxtecan-decreases-risk-of-disease-progression-and-death-in-her2-positive-breast-cancer-nejm-90641
Trastuzumab deruxtecan decreases risk of disease progression and death in HER2 positive breast cancer: NEJM